There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Trevi Therapeutics (TRVI – Research Report), Oculis Holding (OCS – Research Report) and Quanterix (QTRX – Research Report) with bullish sentiments.
Trevi Therapeutics (TRVI)
Leerink Partners analyst Thomas Smith reiterated a Buy rating on Trevi Therapeutics on March 20 and set a price target of $6.00. The company’s shares closed last Friday at $3.59, close to its 52-week high of $4.00.
According to TipRanks.com, Smith is a top 100 analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Trevi Therapeutics with a $7.40 average price target, implying a 98.9% upside from current levels. In a report issued on March 21, Needham also maintained a Buy rating on the stock with a $8.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Oculis Holding (OCS)
In a report issued on March 20, Marc Goodman from Leerink Partners maintained a Buy rating on Oculis Holding, with a price target of $22.00. The company’s shares closed last Friday at $11.73.
According to TipRanks.com, Goodman is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Oculis Holding with a $27.20 average price target, a 130.5% upside from current levels. In a report issued on March 18, Robert W. Baird also reiterated a Buy rating on the stock with a $35.00 price target.
Quanterix (QTRX)
In a report issued on March 20, Puneet Souda from Leerink Partners maintained a Buy rating on Quanterix. The company’s shares closed last Friday at $23.33.
According to TipRanks.com, Souda is ranked 0 out of 5 stars with an average return of
Quanterix has an analyst consensus of Strong Buy, with a price target consensus of $31.67, which is a 31.8% upside from current levels. In a report issued on March 21, Goldman Sachs also reiterated a Buy rating on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on TRVI:
